The report “Enteric Disease Testing Market by Technology (Traditional and Rapid), End Use (Food (Meat, Poultry, Seafood, Dairy, Processed Foods, and Fruits & Vegetables) and Water), Pathogen Tested, and Region – Global Forecast to 2026″, The market for enteric disease testing is estimated at USD 1.8 billion in 2021; it is projected to grow at a CAGR of 6.0% to reach USD 2.4 billion by 2026. The increase in global food production impacts the growth of the food enteric disease testing market by increasing the number of food safety controls in each step from raw material procurement until the product reaches consumers. Further, food manufacturers are willing to pay for testing and certification and have included this practice in their manufacturing cycles. With consumers becoming increasingly aware of food and water-borne illnesses and stringent regulations to meet international standards, there is growing demand for enteric disease testing market.

The enteric disease testing market is affected by several factors, including:

• Prevalence of Enteric Diseases: The prevalence of enteric diseases such as diarrhea, food poisoning, and other infections has a significant impact on the demand for enteric disease testing.
• Technological Advancements: Advances in technology have made it possible to develop more accurate and efficient diagnostic tests for enteric diseases, leading to increased demand for testing.
• Government Initiatives: Government initiatives to control the spread of enteric diseases, such as vaccination programs, have a direct impact on the demand for testing.
• Healthcare Infrastructure: The availability and accessibility of healthcare infrastructure, including testing facilities, in a particular region affect the demand for enteric disease testing.
• Awareness and Education: Awareness and education campaigns can help people understand the importance of early detection and treatment of enteric diseases, leading to increased demand for testing.
• Economic Factors: Economic factors such as disposable income, healthcare expenditures, and insurance coverage can impact the demand for enteric disease testing.
• COVID-19 Pandemic: The COVID-19 pandemic has had an indirect impact on the enteric disease testing market, as healthcare systems and resources have been diverted to address the pandemic, potentially leading to delays or decreased testing capacity for enteric diseases.

Key players in this market include SGS SA (Switzerland), Eurofins Scientific (Luxembourg), Intertek Group plc (UK), Bureau Veritas (France), ALS Limited (Australia), and TÜV SÜD (Germany). Key players in this market are focusing on increasing their presence through mergers and acquisitions and new product developments, specific to consumer tastes in these regions. These companies have a strong presence in Europe and North America. They also have manufacturing facilities and strong distribution networks across these regions.